Differential vulnerability of anterior cingulate cortex cell types to diseases and drugs

Marissa A Smail1,2, Sapuni S Chandrasena3, Xiaolu Zhang4

  • 1Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH, USA.

Molecular Psychiatry
|June 26, 2022
PubMed

Insights

Psychiatric disorders reveal cell-type vulnerabilities and drug responses using single-nucleus RNA sequencing (sn-RNAseq). Findings explain how diseases and treatments impact neural circuits, guiding future therapeutic strategies.

Area of Science:

  • Neuroscience
  • Genomics
  • Pharmacology

Background:

  • Psychiatric disorders present significant challenges due to a lack of understanding regarding cell-type specific vulnerabilities and drug responses.
  • Key questions remain about which cellular events are most affected, which cell types are most vulnerable, and how these are coordinated across cell types during disease and treatment.

Purpose of the Study:

  • To analyze single-nucleus RNA sequencing (sn-RNAseq) data from the human anterior cingulate cortex to understand cell-type specific responses in psychiatric disorders.
  • To identify cell-type vulnerabilities, druggabilities, and responsiveness by integrating functional profiles with disease and drug signatures.

Main Methods:

  • Utilized single-nucleus RNA sequencing (sn-RNAseq) data from the human anterior cingulate cortex.
  • Employed the density index metric to quantify similarities and dissimilarities across functional profiles.
  • Integrated cell-specific signatures with existing disease and drug-specific signatures.

Main Results:

  • Identified specific cell types, notably SST and VIP interneurons, as most vulnerable, while pyramidal neurons were least vulnerable.
  • Revealed that the disease state is superficial layer-centric, affecting cell-specific themes and disinhibitory neurons.
  • Demonstrated that in disease states, drug actions are deep layer-centric, activating specific pyramidal neurons to counteract circuit malfunctions.

Conclusions:

  • Single-nucleus RNA sequencing (sn-RNAseq) offers a novel approach to understanding drug and disease mechanisms at a systems level.
  • Findings illuminate the complex interplay between cell types in psychiatric disorders and their differential responses to therapeutic interventions.
  • The study provides insights into potential mechanisms behind drug side effects and identifies targeted neuronal populations for therapeutic strategies.